April 21, 2023
April 21, 2023
Categories

Lancet Digital Health publishes the first validation of a CT-based deep learning tool for pre-treatment identification of head and neck cancer patients with high-risk, aggressive disease (in the context of the E3311 trial)

Do you like it?
Read more
January 5, 2023
January 5, 2023
Categories

The Winter 2023 advocacy blog Considering Clinical Trials is now available

Do you like it?
Read more
December 20, 2022
December 20, 2022
Categories

The November/December 2022 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
October 21, 2022
October 21, 2022
Categories

Press Release: Head and neck cancer researchers demonstrate the capability of a deep learning algorithm in the post-surgery setting to assess the stage of disease more accurately using standard CT scans

Do you like it?
Read more
September 26, 2022
September 26, 2022
Categories

The Fall 2022 advocacy blog Considering Clinical Trials is now available

Do you like it?
Read more
June 4, 2022
June 4, 2022
Categories

E3311: No differences in survival outcomes based on tobacco history in HPV-associated head and neck cancer

Do you like it?
Read more
May 27, 2022
May 27, 2022
Categories

Press Release: ECOG-ACRIN research highlights at ASCO 2022

Do you like it?
Read more
May 17, 2022
May 17, 2022
Categories

Media Advisory: ECOG-ACRIN data at ASCO will showcase the Group’s robust research portfolio

Do you like it?
Read more
April 29, 2022
April 29, 2022
Categories

Interview with Dr. Robert Ferris: Head and neck cancer treatment evolution leads the way for future developments

Do you like it?
Read more
Load more
ECOG-ACRIN Cancer Research Group